Table 1 Descriptive statistics on data from insured and uninsured patients
From: Obstacles to successful treatment of hepatitis C in uninsured patients from a minority population
| Â | Total (%) | Insured (%) | Uninsured (%) |
|---|---|---|---|
N (216) | 216 (100%) | 62 (29%) | 154 (71%) |
Age at treatment, years [mean (sd)] (p-value < 0.0001) | 56 (9.3)a | 58.9 (8.89)a | 54.2 (9.16)a |
Sex (p-value 0.3227) | |||
 Male | 109 (50%) | 28 (45%) | 81 (53%) |
 Female | 107 (50%) | 34 (55%) | 73 (47%) |
Race (p-value 0.6111) | |||
 White | 153 (71%) | 41 (66%) | 112 (73%) |
 Black | 59 (27%) | 20 (32%) | 39 (25%) |
 Asian/other | 4 (2%) | 1 (2%) | 3 (2%) |
Ethnicity (p-value 0.9261) | |||
 Hispanic | 123 (57%) | 35 (56%) | 88 (57%) |
 Non-Hispanic | 93 (43%) | 27 (44%) | 66 (43%) |
Race/ethnicity (p-value 0.1072) | |||
 Hispanic | 123 (57%) | 35 (56%) | 88 (57%) |
 Non-Hispanic white | 38 (18%) | 6 (10%) | 32 (21%) |
 Non-Hispanic black | 52 (24%) | 20 (32%) | 32 (21%) |
 Asian/other | 3 (1%) | 1 (2%) | 2 (1%) |
Compliance (p-value 0.1975) | |||
 Yes | 165 (76%) | 51 (82%) | 114 (74%) |
 No | 51 (24%) | 11 (18%) | 40 (26%) |
Complications (p-value 0.2129) | |||
 Yes | 111 (51%) | 36 (58%) | 75 (49%) |
 No | 105 (49%) | 26 (42%) | 79 (51%) |
Pre-treatment viral load, IU/mL [median (range)] (p-value 0.5957) | 1,655,329 (840–166,211,511)b | 1,806,502 (840–166,211,511)b | 1,527,253 (3,888–> 69,000,000)b |
Completed treatmentc (p-value 0.4261) | |||
 Yes | 189 (88%) | 56 (90%) | 133 (86%) |
 No | 27 (13%) | 6 (10%) | 21 (14%) |
SVR status (p-value 0.8874) | |||
 SVR | 172 (80%) | 51 (82%) | 121 (79%) |
 No SVR | 5 (2%) | 1 (2%) | 4 (3%) |
 Not tested for SVR | 39 (18%) | 10 (16%) | 29 (19%) |
Genotype (p-value 0.5619) | |||
 1 | 174 (81%) | 52 (84%) | 122 (79%) |
 2 | 20 (9%) | 5 (8%) | 15 (10%) |
 3 | 15 (7%) | 3 (5%) | 12 (8%) |
 4 | 6 (3%) | 1 (2%) | 5 (3%) |
 Mixed | 1 (0.46%) | 1 (2%) | 0 (0%) |
Cirrhosis (p-value 0.0049) | |||
 Yes | 80 (37%) | 32 (52%) | 48 (31%) |
 No | 136 (63%) | 30 (48%) | 106 (69%) |